Data as of Sep 18, 2026 · Based on 50 AI responses from ChatGPT Search and Google AI Mode · See how Parse measures this
Your brand can be here too.
For a **small biotech whose main goal is to run substantially more experiments without hiring a big automation team**, my default pick is **Opentrons Flex**. The important caveat is that “best” depends on whether you want to **own automation in your lab** or **outsource the physical lab execution**. Platform | Best…
For a small biotech whose main goal is to run substantially more experiments without hiring a big automation team, my default pick is Opentrons Flex.
The important caveat is that “best” depends on whether you want to own automation in your lab or outsource the physical lab execution.
| Platform | Best for | Small-biotech fit | Main tradeoff |
|---|---|---|---|
| Opentrons Flex | In-house liquid handling, sample prep, PCR/NGS, protein workflows | ⭐⭐⭐⭐⭐ | You still own the lab/instrument integration |
| Emerald Cloud Lab | Running experiments remotely without building a robotic lab | ⭐⭐⭐⭐⭐ | Recurring service cost; experiments run at ECL rather than your facility |
| Synthace | Orchestrating/designing complex experiments across existing instruments | ⭐⭐⭐⭐ | More valuable once you have multiple instruments/workflows |
| Traditional robotic workcells | Very high-throughput standardized workflows | ⭐⭐ | Expensive and engineering-heavy for a small team |
Opentrons's Flex is unusually well suited to a small team because it's modular, relatively accessible, and has both no-code and Python programming options. The current Flex starts at $26,400, with application-specific workstations starting around $55,100.
It can handle things like:
It has 1-, 8-, and 96-channel pipettes, a gripper, 12 main deck positions plus staging positions, and swappable modules.
The particularly attractive part for a startup is the open software/API. Scientists can start with a drag-and-drop protocol designer and graduate to Python when they need more sophisticated workflows.
If your real objective is “I don't want to build and maintain a robotics lab; I just want my scientists to run 5× as many experiments”, I'd seriously consider Emerald Cloud Lab.
ECL gives you remote access to a large automated facility with 200+ instrument models, including PCR/qPCR, HPLC, mass spectrometry, NMR, flow cytometry, ELISA, SPR/BLI, and many other capabilities.
That's compelling for a small biotech because you can potentially avoid purchasing a lot of capital equipment and avoid spending your scientists' time operating it. ECL specifically offers startup plans; its current pricing page shows a startup comprehensive plan at $30,020/month, with discounted annual pricing and a lower startup-discount figure shown on the page.
So I'd frame the decision this way:
If you have a wet lab already → buy a Flex.
If you don't want to build a wet lab → investigate ECL first.
If you already have several instruments and your bottleneck is coordinating them → look at Synthace. Synthace is more of an experiment-design/automation software layer, with integrations to equipment you already have rather than simply being a robot.
If you tell me what kind of biotech you are (cell therapy, protein engineering, synthetic biology, drug discovery, diagnostics, etc.), roughly how many experiments/week you run now, and your automation budget, I can narrow this down to a specific platform/workstation and estimate the likely throughput gain.
For a small biotech, the "best" lab-automation platform isn’t a massive, multi-million-dollar robotic track system. Small teams need **flexibility, low footprint, fast setup, and strong software integration** rather than rigid, hyper-customized mega-cells. Lab automation is split into three layers—**liquid handlers…
For a small biotech, the "best" lab-automation platform isn’t a massive, multi-million-dollar robotic track system. Small teams need flexibility, low footprint, fast setup, and strong software integration rather than rigid, hyper-customized mega-cells.
Lab automation is split into three layers—liquid handlers (the muscle), scheduling/integration software (the brain), and R&D data tracking (the record).
The top platforms best suited for small biotechs scaling their experiment throughput are categorized below by their strengths:
To help narrow this down, tell me:
If you’re a **small biotech trying to increase experimental throughput without building a huge automation team**, my default pick today is **Opentrons Flex**. ### My shortlist Platform | Best for | Small-biotech fit | Main tradeoff
If you’re a small biotech trying to increase experimental throughput without building a huge automation team, my default pick today is Opentrons Flex.
| Platform | Best for | Small-biotech fit | Main tradeoff |
|---|---|---|---|
| Opentrons Flex | In-house liquid handling, assay/sample prep, PCR, NGS | ⭐⭐⭐⭐⭐ | You still own/operate the hardware |
| Emerald Cloud Lab | Running lots of experiments without building the lab automation stack | ⭐⭐⭐⭐ | High recurring cost; less physical control |
| Strateos | Cloud lab + sophisticated automated workflows | ⭐⭐⭐⭐ | More suited to larger/complex programs |
| Hamilton/Tecan | High-throughput, mature production-like workflows | ⭐⭐⭐ | Powerful but usually overkill for an early lab |
The Flex starts at about $26,400 and is modular: you can add 1-, 8-, or 96-channel pipetting, a gripper, thermocycler, heater/shaker, magnetic block, etc.
More importantly for a small team, the software is relatively open. You can use no-code protocol design or its Python API, and the platform is explicitly designed to integrate with other instruments rather than locking you into a proprietary ecosystem.
That makes it particularly attractive if your bottleneck is something like:
For example, the Flex PCR workstation can automate PCR setup and thermocycling, while the NGS workstation targets pre-sequencing library prep.
If your real goal is "I want my scientists to specify experiments and have a remotely operated facility execute them", rather than "I want a robot in our lab," I'd seriously consider Emerald Cloud Lab.
ECL provides the instrumentation, automation, data acquisition, storage and analysis infrastructure, so you avoid buying and maintaining a fleet of instruments. It explicitly offers startup-company plans.
The catch is economics: its startup pricing is on the order of tens of thousands of dollars per month, so it makes much more sense when you're generating enough experiments to utilize a cloud lab heavily—or when avoiding capital expenditure and hiring automation personnel is particularly valuable.
Buy Opentrons Flex if you have a physical lab and your experiments are mostly standardized liquid-handling workflows.
Use Emerald Cloud Lab if you want to outsource the physical execution of experiments and maximize experimental capacity without building automation infrastructure.
Move toward Hamilton/Tecan + an orchestration layer when you've proven the workflow and are approaching sustained, industrial-scale throughput.
The key question isn't really which robot is best. It's what is currently limiting your experiments: pipetting labor, instrument availability, sample processing, assay execution, or scientist time?
If you tell me what kind of biotech you are (e.g. cell therapy, synthetic biology, antibody discovery, genomics) and roughly how many experiments/well plates you run per week, I can give you a much more concrete recommendation—including estimated $/experiment and what I'd automate first.
For a small biotech, the "best" lab-automation platform isn't a massive, multi-million-dollar `rigid robotic track system` . Small teams need **flexibility, rapid deployment, and unified data tracking** so scientists spend time doing science rather than troubleshooting macro scripts or wrestling with siloed instrument…
For a small biotech, the "best" lab-automation platform isn't a massive, multi-million-dollar rigid robotic track system . Small teams need flexibility, rapid deployment, and unified data tracking so scientists spend time doing science rather than troubleshooting macro scripts or wrestling with siloed instrument files.
The top lab-automation and orchestration platforms tailored for small-to-midsize biotech scaling their throughput are categorized below by their strengths:
To help narrow this down, tell me:
For a small biotech aiming to scale up experiments without massive capital expenditure, **[Opentrons](https://opentrons.com/) (specifically the OT-2 or Flex systems)** is the best fit for physical liquid handling, paired with cloud software like **Benchling** or **Scispot** for data orchestration. Traditional…
For a small biotech aiming to scale up experiments without massive capital expenditure, Opentrons (specifically the OT-2 or Flex systems) is the best fit for physical liquid handling, paired with cloud software like Benchling or Scispot for data orchestration.
Traditional automation giants (like Tecan or Hamilton) offer incredible throughput, but they require dedicated engineering staff, massive floor space, and hundreds of thousands of dollars. Small biotechs need agility, low cost, and ease of programming.
Top Lab-Automation Platforms for Small Biotechs
| Platform / Tool | Best For | Key Advantage | Estimated Cost Tier |
|---|---|---|---|
| Opentrons OT-2 / Flex | Affordable benchtop liquid handling | Open-source Python API, highly flexible, compact footprint | Low ($10k – $30k) |
| Benchling | R&D data tracking and ELN | Industry standard for molecular biology workflows and sample tracking | Mid (Subscription) |
| Scispot | Configurable lab operating system | Built specifically for modern biotech startups to connect data & workflows | Mid (Subscription) |
| Emerald Cloud Lab | Outsourcing full remote labs | Zero hardware footprint; access to hundreds of automated high-end instruments remotely | High (Pay-per-run) |
Choosing the Right Strategy
To narrow down the ideal stack, tell me:
For a **small biotech**, the “best” lab-automation platform is usually not the biggest robot — it’s the one that removes your current bottleneck without creating a new operations burden. The right choice depends heavily on whether you are doing **NGS, screening, cell assays, protein work, synthetic biology, or…
For a small biotech, the “best” lab-automation platform is usually not the biggest robot — it’s the one that removes your current bottleneck without creating a new operations burden. The right choice depends heavily on whether you are doing NGS, screening, cell assays, protein work, synthetic biology, or chemistry.
A practical shortlist:
| Platform | Best fit | Why small biotechs like it | Main tradeoff |
|---|---|---|---|
| Opentrons Labworks | Early-stage biotech, molecular biology, NGS prep, PCR, sample prep | Lower barrier to entry, modular hardware, open software, easier iteration | Less suited for massive 24/7 production throughput Opentrons.com Opentrons.com |
| Hamilton Company | Scaling biotech labs, complex liquid handling | Very robust, strong integration ecosystem, common in pharma | Higher cost and more engineering overhead IntuitionLabs |
| Tecan Group | High-throughput workflows | Mature automation platforms and integrations | Often requires more upfront investment IntuitionLabs |
| Beckman Coulter Life Sciences | Screening, assays, regulated workflows | Strong enterprise capabilities | Usually overkill for a very small team IntuitionLabs |
| Emerald Cloud Lab / Strateos | Teams that want experiments without building a lab | Avoids buying and maintaining robots | Less control for unusual protocols pdpspectra |
1–10 scientists, still iterating on biology
10–50 scientists, experiments are piling up
High-throughput screening or production-like biology
If you tell me:
I can narrow this to 2–3 platforms and a likely architecture.
For a **small biotech**, the “best” lab-automation platform usually depends less on raw throughput and more on **how much capital you have, how standardized your experiments are, and whether you want to own the lab**. A practical shortlist: Platform | Best fit | Why small biotechs choose it | Main trade-off
For a small biotech, the “best” lab-automation platform usually depends less on raw throughput and more on how much capital you have, how standardized your experiments are, and whether you want to own the lab.
A practical shortlist:
| Platform | Best fit | Why small biotechs choose it | Main trade-off |
|---|---|---|---|
| Opentrons Labworks | Early-stage biotech building its first automation layer | Low-cost, flexible benchtop robots; good for NGS prep, PCR setup, cloning, sample prep, and custom workflows | You still own the integration burden and may outgrow it for very high throughput Opentrons.com |
| Emerald Cloud Lab | Teams that want experiments without building a wet lab | Access to a large automated facility; useful when lab space, hiring, and instrument purchases are bottlenecks | Less control over unusual/custom workflows; economics depend on utilization Emerald Cloud Lab |
| Strateos | Synthetic biology, screening, and outsourced automated execution | Remote execution of standardized workflows with automation and data systems | You are dependent on their available workflows and capacity strateos |
| Hamilton Company / Tecan | A biotech with stable, high-volume protocols | Industrial-grade reliability and throughput | Higher upfront cost and more engineering support required pdpspectra |
Start with:
This usually gives the fastest productivity gain without locking the company into a huge infrastructure decision.
Consider:
This can be attractive because you trade capital expense and lab operations for service spend.
Move toward:
At that point, automation becomes a core engineering capability rather than just a robot purchase.
If I were advising a typical seed-to-Series A biotech, I would usually start with Opentrons (or similar modular automation) for the workflows you repeat every day, while using a cloud lab for experiments that require expensive instruments or burst capacity.
If you tell me your modality (synthetic biology, therapeutics, antibodies, cell therapy, diagnostics, AI-designed proteins, etc.) and approximate experiment volume, I can narrow this to a specific platform choice.
For a **small biotech** , the "best" lab automation platform isn’t a massive, multi-million-dollar rigid robotic track system (like those built for big pharma). Instead, small biotechs need **agility, modularity, and strong digital tracking** so they can pivot assays quickly without needing a dedicated full-time…
For a small biotech , the "best" lab automation platform isn’t a massive, multi-million-dollar rigid robotic track system (like those built for big pharma). Instead, small biotechs need agility, modularity, and strong digital tracking so they can pivot assays quickly without needing a dedicated full-time robotics engineering team.
The ideal platform choice depends on whether you are looking for benchtop hardware/liquid handling or the software backbone to tie your experiments together:
Before buying expensive hardware, small biotechs usually suffer from fragmented data and manual record-keeping. Connecting your instruments to a unified platform is critical.
If your bottleneck is manual pipetting, serial dilutions, or plate prep, you need a flexible automated workstation:
Strategy for a Small Biotech
To narrow this down, tell me:
FireFly
For a small biotech, the "best" lab-automation platform isn't a massive, multi-million dollar robotic track system. Instead, it’s a **high-flexibility, software-driven ecosystem** that scales with you without requiring a dedicated robotics engineering team. Small biotechs typically need to maximize bench space, adapt…
For a small biotech, the "best" lab-automation platform isn't a massive, multi-million dollar robotic track system. Instead, it’s a high-flexibility, software-driven ecosystem that scales with you without requiring a dedicated robotics engineering team.
Small biotechs typically need to maximize bench space, adapt quickly to pivoting scientific hypotheses, and keep upfront capital expenditures reasonable.
The top lab-automation platforms for small biotechs are categorized below by their primary strengths:
To help narrow down the ideal setup for your team, tell me:
For a **small biotech whose goal is simply to run substantially more experiments without hiring a huge automation team**, my default pick today would be **Opentrons Flex**. [opentrons.com](https://opentrons.com/robots/flex?utm_source=chatgpt.com) ### My shortlist
For a small biotech whose goal is simply to run substantially more experiments without hiring a huge automation team, my default pick today would be Opentrons Flex.
| Platform | Best for | My take for a small biotech |
|---|---|---|
| Opentrons Flex | Flexible in-house liquid handling | Best default |
| Emerald Cloud Lab | Outsourcing the physical lab entirely | Best if you don't want to build/operate automation |
| Benchling Automation | Connecting instruments + experiment/data layer | Best as an orchestration/data layer, particularly if already on Benchling |
| Strateos | Cloud/on-demand automated R&D | Strong alternative to ECL, especially for drug-discovery workflows |
| Hamilton/Tecan workcells | Very high-throughput, standardized workflows | Excellent, but often overkill for an early-stage team |
The economics and flexibility are unusually attractive for a small team. Opentrons lists Flex configurations starting around $26,400, with an NGS workstation starting around $55,100. It's modular: you can swap 1-, 8-, and 96-channel pipettes, add a gripper and modules, and reconfigure the deck as your assays evolve.
More importantly, you're not locked into a proprietary automation ecosystem. Flex has an open-source software/firmware stack, a Python API, a no-code Protocol Designer, and broad labware compatibility.
That makes it particularly good for a startup where the assay is likely to change faster than the automation requirements.
If your real objective is "I want to give a cloud service samples and have them run hundreds/thousands of different experiments while my scientists stay focused on computational work," I'd seriously consider Emerald Cloud Lab instead.
ECL operates a fully automated remote lab with 200+ instrument models and supports workflows ranging from sample prep and PCR to chromatography, mass spectrometry, cell biology and high-throughput experimentation. You ship samples in, specify experiments remotely, and get the resulting data back.
That's a fundamentally different proposition:
Flex: buy ~$30k–$100k+ of automation → build capability inside your lab → low marginal cost per experiment.
ECL: don't build the automation → pay for experimental capacity → potentially much faster to get started.
If you're already using Benchling, I'd look closely at Benchling Automation. It is hardware-agnostic and currently advertises 200+ instrument connectors, visual workflow construction, automated analysis, and integration with platforms including Opentrons, Hamilton and others.
I wouldn't view Benchling as a replacement for the robot. I'd view it as the software/data layer sitting above your robots and instruments.
If you tell me what experiments you're running (e.g. cell culture, cloning, NGS, protein assays, ELISA, screening, synthetic biology) and roughly how many experiments/well plates per week, I can give you a much more concrete recommendation—including what I'd automate first and an approximate setup/budget.
| Platform | Best for | My take for a small biotech |
|---|---|---|
| Opentrons Flex | Flexible in-house liquid handling | Best default |
| Emerald Cloud Lab | Outsourcing the physical lab entirely | Best if you don't want to build/operate automation |
| Benchling Automation | Connecting instruments + experiment/data layer | Best as an orchestration/data layer, particularly if already on Benchling |
| Strateos | Cloud/on-demand automated R&D | Strong alternative to ECL, especially for drug-discovery workflows |
| Hamilton/Tecan workcells | Very high-throughput, standardized workflows | Excellent, but often overkill for an early-stage team |
The economics and flexibility are unusually attractive for a small team. Opentrons lists Flex configurations starting around $26,400, with an NGS workstation starting around $55,100. It's modular: you can swap 1-, 8-, and 96-channel pipettes, add a gripper and modules, and reconfigure the deck as your assays evolve.
More importantly, you're not locked into a proprietary automation ecosystem. Flex has an open-source software/firmware stack, a Python API, a no-code Protocol Designer, and broad labware compatibility.
That makes it particularly good for a startup where the assay is likely to change faster than the automation requirements.
If your real objective is "I want to give a cloud service samples and have them run hundreds/thousands of different experiments while my scientists stay focused on computational work," I'd seriously consider Emerald Cloud Lab instead.
ECL operates a fully automated remote lab with 200+ instrument models and supports workflows ranging from sample prep and PCR to chromatography, mass spectrometry, cell biology and high-throughput experimentation. You ship samples in, specify experiments remotely, and get the resulting data back.
That's a fundamentally different proposition:
Flex: buy ~$30k–$100k+ of automation → build capability inside your lab → low marginal cost per experiment.
ECL: don't build the automation → pay for experimental capacity → potentially much faster to get started.
If you're already using Benchling, I'd look closely at Benchling Automation. It is hardware-agnostic and currently advertises 200+ instrument connectors, visual workflow construction, automated analysis, and integration with platforms including Opentrons, Hamilton and others.